Holmes Documentary 'You Can See Everything' Sparks Oscar Controversy Amidst Record Acclaim

Key points

• The film follows Holmes and her partner Billy Evans in San Diego as they develop a new medical device, with Fielder actively participating in the narrative.
• Critics praise the film’s psychological depth and meta-commentary, noting that it leaves audiences questioning the authenticity of both Holmes and Fielder.
• Variety reports the film could become the first documentary nominated for Best Picture, a feat no nonfiction film has achieved in 98 years.
• The documentary has caused a complete breakdown in communication between the filmmakers and Holmes/Evans, who have not seen the finished product.
• The film opens in theaters on October 16, 2026, following record-breaking presales at Alamo Drafthouse.

Background

The film premiered at the New York Film Festival in early October 2026 to intense acclaim. Prior coverage noted that the documentary’s hybrid nature, featuring Fielder as a participant, complicates its path through traditional award categories, including acting and best picture. The film has also been noted for severing ties between the filmmakers and their subjects.

How outlets are covering it

SlashFilm emphasizes the film’s 'mind-melting manipulation' and psychological complexity, highlighting the dynamic between Holmes and Evans. AP News describes the film as an 'absurd, entertaining search for truth,' focusing on its narrative structure. Variety focuses on the film’s potential to break Academy barriers, noting that the documentary branch’s insular voting habits may hinder its Best Picture chances, despite its widespread popularity among the broader Academy membership.

Why it matters

The film’s potential Best Picture nomination challenges the Academy’s traditional separation between fiction and nonfiction categories. Its success also highlights the growing influence of meta-documentary styles in mainstream cinema and the ongoing cultural fascination with the Theranos scandal.

What to watch

The film will open in theaters on October 16, 2026. The Academy’s documentary branch will release its shortlist in December, which will determine whether the film can advance to a Best Picture nomination.